NewSquare Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.2K | Sell |
115
-12
| -9% | -$5.34K | ﹤0.01% | 282 |
|
|
2025
Q1 | $61.6K | Buy |
127
+117
| +1,170% | +$56.7K | 0.01% | 216 |
|
|
2024
Q4 | $4.03K | Buy |
+10
| New | +$4.03K | ﹤0.01% | 395 |
|
|
2023
Q4 | – | Sell |
-59
| Closed | -$20.5K | – | 639 |
|
|
2023
Q3 | $20.5K | Buy |
59
+49
| +490% | +$17K | ﹤0.01% | 245 |
|
|
2023
Q2 | $3.52K | Hold |
10
| – | – | ﹤0.01% | 460 |
|
|
2023
Q1 | $3.15K | Hold |
10
| – | – | ﹤0.01% | 511 |
|
|
2022
Q4 | $2.89K | Buy |
+10
| New | +$2.89K | ﹤0.01% | 436 |
|
|
2020
Q3 | – | Sell |
-5,535
| Closed | -$1.61M | – | 425 |
|
|
2020
Q2 | $1.61M | Buy |
5,535
+980
| +22% | +$285K | 0.27% | 83 |
|
|
2020
Q1 | $1.08M | Buy |
+4,555
| New | +$1.08M | 0.2% | 86 |
|
|
2016
Q4 | – | Sell |
-151
| Closed | -$13K | – | 469 |
|
|
2016
Q3 | $13K | Hold |
151
| – | – | ﹤0.01% | 241 |
|
|
2016
Q2 | $13K | Sell |
151
-20
| -12% | -$1.72K | ﹤0.01% | 242 |
|
|
2016
Q1 | $14K | Buy |
171
+153
| +850% | +$12.5K | ﹤0.01% | 260 |
|
|
2015
Q4 | $2K | Hold |
18
| – | – | ﹤0.01% | 315 |
|
|
2015
Q3 | $2K | Hold |
18
| – | – | ﹤0.01% | 285 |
|
|
2015
Q2 | $2K | Hold |
18
| – | – | ﹤0.01% | 317 |
|
|
2015
Q1 | $2K | Hold |
18
| – | – | ﹤0.01% | 288 |
|
|
2014
Q4 | $2K | Hold |
18
| – | – | ﹤0.01% | 292 |
|
|
2014
Q3 | $2K | Hold |
18
| – | – | ﹤0.01% | 301 |
|
|
2014
Q2 | $2K | Buy |
+18
| New | +$2K | ﹤0.01% | 258 |
|